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PURPOSE. Describe changes in the retina as vision loss progresses in Leber’s Hereditary Optic
Neuropathy (LHON) using spectral-domain optical coherence tomography (SD-OCT)
autosegmentation, and determine if relationship exists between retinal changes and vision
loss.
METHODS. From patient records we identified nine LHON patients who underwent periodic
neuro-ophthalmologic examinations and high-resolution SD-OCT as part of their care. We
describe the impact of LHON progression on each retinal layer, and the relationship between
these structural changes and visual acuity using generalized estimating equations and
nonparametric tests.
RESULTS. The thickness of the ganglion cell layer (GCL) and inner plexiform layer (IPL)
decreased immediately or soon after symptom onset, and this decrease was associated with
worsening vision: in the GCL a 1-mm3 volume loss was associated with a 3.2 increase in
logMAR visual acuity (95% confidence interval [CI]: 2.1–4.1); in the IPL a 1-mm3 volume loss
was associated with a 4.9 increase in visual acuity (95%CI: 6.5–3.2). The retinal nerve fiber
layer (RNFL) also thinned, but not until after the GCL and IPL, and only in the papillomacular
bundle (PMB) and temporal layers was thinning associated with vision loss.
CONCLUSIONS. For the first time these analyses describe a structure-function relationship
between the retinal changes that occur in LHON patients as their disease progresses and
vision worsens. The structural changes in the GCL, IPL, and RNFL preceded structural
changes in the other retinal layers. This analysis suggests that the first 6 months after diagnosis
define a target for therapeutic intervention, and this can inform treatment guidelines for
ongoing therapeutic trials.
Keywords: Leber’s hereditary optic neuropathy, optical coherence tomography, ganglion cell
Leber’s Hereditary Optic Neuropathy (LHON) is a mitochon-drially inherited disorder characterized by progressive
bilateral central vision loss. Ninety percent of cases are due
to three mitochondrial DNA point mutations that disrupt
oxidative phosphorylation, leading to the death of retinal
ganglion cells.1 Leber’s Hereditary Optic Neuropathy preferen-
tially affects smaller axons, such as the papillomacular bundle
(PMB).2 In patients who develop decreased vision, the loss
often begins unilaterally and progresses painlessly over days to
weeks to levels of 20/200 or worse.1,3 Most patients will
develop vision loss in the second eye within 8 weeks, with
approximately 97% of patients having involvement of both eyes
within 1 year.3,4 Occasionally some visual recovery occurs.4–7
Penetrance is incomplete, with approximately 25% of male
mutation carriers and 5% of female mutation carriers develop-
ing symptoms over their lifetime.4,8,9 This incongruence may
be related to multiple factors, including heteroplasmy, thresh-
old expression, and a protective effect of estrogen on cells with
dysfunctional mitochondria.
Strong evidence exists that the retinal structures change
around the time of the onset of symptoms, although the precise
nature of these changes still remains incompletely character-
ized. Both swelling and atrophy in retinal structures have been
reported.10–12 Many previous investigations have used time-
domain optical coherence tomography (TD-OCT) to describe
the retinal structures, but the resolution and reproducibility of
TD-OCT measurements is quite limited.2,13 Additionally, evi-
dence has emerged that structural changes in the retina are
associated with vision loss, although there is conflicting
evidence for whether changes in the retinal nerve fiber layer
(RNFL), the ganglion cell layer (GCL), or both are the initial
indicators of the vision loss.10–12,14 This research has not yet
established whether swelling or thinning is associated with
vision loss, and has not determined whether the changes
precede or follow the vision loss.
If there is a causal relationship between structural changes
and vision loss, this may present a therapeutic window in
which intervening to halt the structural changes might preserve
vision in LHON patients.10 Recent advances in Spectralis OCT
have allowed for SD-OCT measurements that have improved
resolution, decreased variability, and an automated algorithm to
quantify the retinal layers. These higher-resolution measure-
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ments have not yet been applied to examine the structure of
the retina as LHON progresses.
The primary objective of our study was to use the high-
resolution Spectralis SD-OCT system (software version 5.3.2;
Heidelberg Engineering, Heidelberg, Germany) to quantify the
thickness of the sublayers in the RNFL, GCL, inner plexiform
layer (IPL), inner nuclear layer (INL), outer plexiform layer
(OPL), and outer nuclear layer (ONL), and the volume of each
of these layers, in the months surrounding the onset of
symptoms in LHON patients. The secondary objective of our
study was to establish a relationship between any changes in
the retinal structures and visual acuity. Taken together, our
longitudinal analyses may identify a therapeutic window and
target where interventions that halt retinal changes may be
applied to preserve visual function in LHON patients before
atrophic changes develop.
METHODS
Subjects
We conducted a chart review and identified nine consecutive
unrelated LHON patients seen at the Wills Eye Hospital Neuro-
Ophthalmology Service (Philadelphia, PA, USA) between
December 2010 and April 2013. All had LHON mutation status
determined by Athena laboratories.15 Participants were to be
excluded due to a co-occurrence of glaucoma, macular
degeneration, 6 diopters (D) or more of myopia, hyperopia,
high IOP, or cataract surgery. None of the nine patients met
these exclusion criteria. At baseline and as part of their clinical
follow-up, these patients underwent periodic neuro-ophthal-
mologic examinations and SD-OCT imaging. Patients were
followed clinically for up to 2 years. This retrospective cohort
study follows the tenets of the Declaration of Helsinki, and the
study received approval from the institutional review board of
Wills Eye Hospital.
Assessment of Retinal Characteristics Using
Spectral-Domain OCT
To measure retinal characteristics, we implemented high-
resolution SD-OCT (Spectralis). The automated retinal segmen-
tation measured the optic nerve head and posterior pole retinal
thickness, identified each retinal layer, and quantified their
thicknesses and the total volume. For the RNFL, SD-OCT
calculated a thickness for the superior, temporal, PMB, inferior,
and nasal layers. For each of the GCL, INL, IPL, ONL, and IPL,
SD-OCT calculated total volume, as well as retinal thickness
values for the three concentric rings at 1 (central fovea), 3
(inner/parafoveal ring), and 6 mm (outer/perifoveal ring),
breaking the inner and outer rings into four quadrants (nasal,
superior, temporal, and inner), creating nine total measure-
ments per retinal layer, corresponding to the Early Treatment
Diabetic Retinopathy Study areas.16
The assessments were performed by our technician using a
method certified in multiple clinical trials. Scans were repeated
three times and only high-quality (Q values > 20) scans were
FIGURE 1. Topographic results of retinal layer segmentation during presymptomatic stage (top) and 3 months after onset (bottom).
TABLE 1. Patient Characteristics
Age
Median (interquartile range) 29 (19)
Mutation type (n)
3460 1
11778 5
14484 3
Baseline symptoms (n)
No eyes symptomatic at baseline 1
1 eye symptomatic at baseline 3
2 eyes symptomatic at baseline 5
Number of SD-OCT examinations (n)
1 exam 2
2 exams 3
3 exams 2
4 exams 1
5 exams 1
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included. Segmentation results were manually adjusted to
ensure accuracy.
Assessment of Visual Acuity and Ophthalmologic
Exam
During the neuro-ophthalmologic examination, the patients were
examined to assess their pupils, retina, color vision, IOP, and a
Humphrey 24-2 visual field examination was performed. Best
corrected visual acuity (BCVA) was measured with a Snellen
chart, and visual acuities were analyzed using logMAR methods.17
Statistical Analysis
Qualitatively, we described the relationships between thick-
ness and volume of retinal structures as a function of time, and
described visual acuity as a function of thickness and volume,
with scatterplots fitted with a locally weighted regression
(LOESS) smoothed nonparametric regression line.18
Quantitatively, we described the structural changes of
each retinal layer over the follow-up period by implementing
a generalized estimating equation (GEE) to calculate the
slope of each thickness or volume over time, after
accounting for age and within-patient intereye correlations.
In layers where a statistically significant change was seen
between retinal structure and disease duration, we used the
nonparametric Wilcoxon rank sum test to identify the time
period in which the median thickness first became
statistically different from the thicknesses measured in
presymptomatic eyes.
To quantitatively assess how changes in retinal layers were
associated with visual function, we implemented a GEE to
TABLE 2. GEE Estimates for the Effect of Time on the Volume of the Retinal Layers, and the Effect of Volume of the Retinal Layers on Visual Acuity
Volume Over Time Visual Acuity as a Function of Volume
Estimated Change in
Volume Per Month, mm3
Standard
Error
95% Confidence
Interval
Estimated Effect of 1-mm3
Increase in Volume on
logMar Visual Acuity
Standard
Error
95% Confidence
Interval
GCL 0.0181 0.0030 (0.024, 0.01238)* 3.19 0.50 (4.11, 2.12)*
IPL 0.0104 0.0018 (0.0142, 0.00697)* 4.88 0.86 (6.51, 3.17)*
INL 0.0027 0.0010 (0.00068, 0.00462)* 1.43 1.87 (2.39, 4.76)
OPL 0.0011 0.0016 (0.00193, 0.00452) 1.26 1.39 (1.31, 4.12)
ONL 0.0021 0.0029 (0.00365, 0.00762) 1.63 0.54 (0.42, 2.63)*
Slopes that are significant at the P < 0.05 level are marked with an asterisk.
FIGURE 2. Macular volume during LHON progression.
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calculate the effect of thickening or thinning of each retinal
layer on visual function, after accounting for age, disease
duration, and within-patient intereye correlations. Analyses
were performed using R version 3.2.2.
RESULTS
Characteristics of the participants in the trial are listed in
Table 1. Mutation 11778 was the most common mutation
responsible for LHON, occurring in five participants,
followed by mutation 14484 (three participants) and
mutation 3460 (one participant). At baseline, most of the
patients (five) had both eyes symptomatic, three were
symptomatic in one eye, and one was symptomatic in
neither eye, but developed symptoms over the course of the
study. The modal patient was examined using SD-OCT twice,
and the number of examinations per patient ranged from
one to five. We did not observe vitreoretinal traction around
the optic disk, fovea, or PMB in any patients at presentation
or during follow-up.
Figure 1 displays the optical output of a typical SD-OCT
scan in the same participant before the onset of symptoms in
that eye (top panel) and 3 months after the onset of symptoms
(bottom panel). All layers showed architectural changes as
LHON progressed, as discussed in detail below.
The SD-OCT algorithm measured the total volume of the
GCL, IPL, INL, OPL, and ONL (Table 2, left; Fig. 2), which
provided a summary of how changes in all components of
these layers change over time. The algorithm also measured
how those changes were associated with visual acuity (Table
2, right; Fig. 3). The volume measurements provided evidence
of progressive thinning in the GCL and IPL, both of which
were significantly associated with vision loss. Additionally,
there was significant swelling in the INL and not statistically
significant swelling in the ONL and OPL. The details of how
the substructures of the RNFL, GCL, and IPL changed with
time and were associated with vision loss are discussed
below. The details of how the INL, OPL, and ONL changed
with time are discussed in detail in the supplemental text.
Retinal Nerve Fiber Layer
The RNFL measurements demonstrated a significant thinning
that occurred after the onset of symptoms in that eye (Table 3,
left; Fig. 4A). The magnitude of the speed of the thinning
varied from layer to layer, with the inferior layer demonstrating
the most dramatic thinning, with an estimated decrease in
thickness of 4 lm/month (CI5.1 to2.9 lm/month) and the
nasal layer thinning at the slowest rate of 1.3 lm/month (CI
1.9 to 0.7 lm/month).
In order to better quantify when these changes occurred,
we calculated the median thickness for measurements taken
within five time windows (Table 4): 15 days before the onset of
symptoms through 15 days after the onset of symptoms; 15
days after onset through 3 months after onset; 3 to 6 months
after onset; 6 to 12 months after onset; and 12 to 24 months
after onset. We then identified the first of these time periods
when the median thickness differed from the thickness taken
in presymptomatic eyes (eyes that were measured more than
FIGURE 3. Visual acuity and macular volume.
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15 days before the onset of symptoms).The thinning in the
temporal layer was the first to reach statistical significance,
with the median thickness of eyes measured between 15 days
and 3 months after the onset of symptoms reaching 73 lm
(confidence interval [CI]: 57–87 lm), compared with 90 lm at
baseline (CI: 75–108 lm). The next layers to demonstrate
significant thinning were the PMB and inferior layers measured
in eyes 3 to 6 months after the onset of symptoms. By 12 to 24
months after onset, all layers were significantly different from
baseline, with the average median thickness decreased by
more than half in most layers.
In the PMB and the temporal layers, we found evidence that
the thinning observed was associated with changes in visual
acuity (Fig. 5; Table 3, right). In the PMB layer, a 10-lm
thinning was associated with a 0.173 increase in logMAR visual
acuity (CI: 0.275 to 0.057 logMAR/lm), and in the temporal
layer, 1-lm thinning was associated with a 0.113 increase in
visual acuity.
Ganglion Cell Layer
All layers in the GCL showed significant thinning over time,
and that thinning was associated with a loss of vision (Tables
3, 5). A qualitative examination of the thickness of the GCL
(Fig. 6) suggests that the thinning in the GCL occurred
around the time of disease onset, and then stabilized at
approximately 6 months. As with the RNFLs, each layer
individually demonstrated a thinning that is statistically
significant at the a¼ 0.05 level (Table 3, left), with the most
rapid thinning occurring in the superior inner layer (1.24
lm/month; CI: 1.61 to 0.86 lm/month), followed by the
temporal inner (1.18 lm/month; CI: 1.57 to 0.8 lm/
month), and inferior inner (1.13 lm/month; CI: 1.52 to
0.74 lm/month) layers.
There is evidence that the thinning in the GCL occurred
possibly before the thinning in the RNFL, because in some
layers the thinning was statistically different from presymp-
tomatic eyes sooner (Table 5). In the temporal inner and
inferior outer layers, the median measurements taken concur-
rent with the onset of symptoms were already significantly
different from measurements taken before symptoms devel-
oped. By 3 months after symptoms developed in the eye, 7 of 9
layers were significantly thinner than predisease in measure-
ments, and all layers were different from baseline by 6 months
after disease onset.
The thinning observed in all layers of the GCL was
correlated with worsening eyesight (Fig. 7; Table 3, right).
Thinning in the center layer of the GCL was estimated to have
the largest impact on visual acuity with 10-lm thinning
associated with a 1.9 increase in logMAR visual acuity (CI:
2.5 to 1.2), followed by the inferior outer layer (10-lm
thinning associated with a 1.5 increase in logMAR visual acuity
(CI: 1.8 to 1.0).
TABLE 3. GEE Estimates for the Effect of Time on the Thickness of the Retinal Layers and the Effect of Thickness of the Retinal Layers on Visual
Acuity
Thickness Over Time Visual Acuity as a Function of Thickness
Estimated Change
in Thickness
Per Month, lm
Standard
Error
95% Confidence
Interval
Estimated Effect of
10 lm increase in Thickness
on logMar Visual Acuity
Standard
Error
95% Confidence
Interval
RNFL
Average 2.78 0.31 (3.46, 2.05)* 0.0054 0.0597 (0.1093, 0.1271)
Superior 2.92 0.47 (3.97, 1.93)* 0.0635 0.0384 (0.0087, 0.1393)
Temporal 2.50 0.37 (3.33, 1.68)* 0.1135 0.0479 (0.2045, 0.0089)*
PMB 1.49 0.31 (2.14, 0.89)* 0.1731 0.0548 (0.2754, 0.0567)*
Inferior 4.00 0.50 (5.08, 2.85)* 0.0098 0.0363 (0.0798, 0.0572)
Nasal 1.29 0.31 (1.93, 0.65)* 0.0613 0.0591 (0.0550, 0.1791)
GCL
Center 0.27 0.05 (0.37, 0.17)* 1.8830 0.2955 (2.4774, 1.1825)*
Nasal inner 1.08 0.20 (1.48, 0.68)* 0.4964 0.0702 (0.6274, 0.3387)*
Nasal outer 0.53 0.09 (0.70, 0.35)* 0.9244 0.1788 (1.2601, 0.5373)*
Superior inner 1.24 0.19 (1.61, 0.86)* 0.4467 0.0862 (0.6052, 0.2582)*
Superior outer 0.52 0.07 (0.66, 0.38)* 0.6718 0.2382 (1.1099, 0.2109)*
Temporal inner 1.18 0.20 (1.57, 0.80)* 0.4772 0.0773 (0.6201, 0.3117)*
Temporal outer 0.68 0.09 (0.87, 0.50)* 0.8713 0.1722 (1.1915, 0.5304)*
Inferior inner 1.13 0.20 (1.52, 0.74)* 0.5005 0.0710 (0.6314, 0.3454)*
Inferior outer 0.34 0.07 (0.48, 0.21)* 1.4572 0.2030 (1.8447, 1.0222)*
IPL
Center 0.23 0.06 (0.34, 0.13)* 1.4548 0.2992 (2.0195, 0.8815)*
Nasal inner 0.71 0.12 (0.95, 0.48)* 0.7946 0.1227 (1.0279, 0.5544)*
Nasal outer 0.28 0.05 (0.39, 0.18)* 1.6677 0.2854 (2.2526, 1.0420)*
Superior inner 0.71 0.11 (0.93, 0.50)* 0.7630 0.1478 (1.0348, 0.4578)*
Superior outer 0.22 0.04 (0.32, 0.14)* 0.9745 0.4167 (1.7597, 0.1699)*
Temporal inner 0.76 0.12 (1.01, 0.53)* 0.6844 0.1298 (0.9275, 0.4337)*
Temporal outer 0.33 0.06 (0.46, 0.22)* 1.0438 0.2778 (1.5663, 0.4961)*
Inferior inner 0.68 0.11 (0.90, 0.47)* 0.8576 0.1344 (1.1055, 0.5803)*
Inferior outer 0.24 0.03 (0.31, 0.18)* 2.3677 0.4748 (3.3115, 1.2884)*
Slopes that are significant at the P < 0.05 level are marked with an asterisks.
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Inner Plexiform Layer
As with the GCL, most of the thinning of the IPL occurred in the
first 6 months after the onset of symptoms in the eye (Fig. 8;
Table 3, left, and Table 6). The inner layers (nasal inner, superior
inner, temporal inner, and inferior inner) showed a larger
decrease in magnitude than the outer layers (Table 3, left). The
magnitude of the thinning in the IPL was less than in the GCL.
The inferior inner layer of the IPL showed significant
thinning at the time of the onset of symptoms, thinning to 37
lm (CI: 29–42 lm) at the time of disease onset compared with
43 lm at baseline (CI: 39–43 lm; Table 6). The nasal inner,
nasal outer, superior inner, temporal inner, and inferior outer
layers were all significantly thinned when compared with
baseline by 3 months after the disease onset, and all nine layers
were significantly thinned by 6 months after the onset of
symptoms.
The thinning observed in the IPL was associated with worse
eyesight, with all layers demonstrating a negative association
between thickness and logMAR visual acuity (Fig. 9; Table 3,
right). When the association was compared with the one
observed in the GCL, the larger standard errors of the estimates
and the increased scatter of the data indicate that this
association between visual acuity and the thickness of the
layers is less precise in the IPL.
FIGURE 4. Retinal nerve fiber layer thickness during LHON progression.
TABLE 4. Median Thickness of the Retinal Nerve Fiber Layer as Symptoms Progress
Median (95%CI)
Presymptomatic
Eye
0.5 mo Before Onset
to 0.5 mo After Onset
0.5–3 mo
After Onset
3–6 mo
After Onset
6–12 mo
After Onset
12–24 mo
After Onset
Average 116 (110, 141) 112 (102, 123) 110 (99, 120) 97 (82, 112)* 92 (70, 112) 60 (51, 85)*
Superior 136 (126, 160) 134 (130, 146) 139 (126, 150) 140 (114, 160) 117 (80, 155) 74 (66, 115)*
Temporal 90 (75, 108) 89 (55, 122) 73 (57, 87)* 48 (37, 62)* 51 (33, 74)* 30 (24, 49)*
PMB 72 (57, 77) 57 (37, 76) 54 (36, 73) 30 (24, 51)* 34 (24, 46)* 26 (20, 36)*
Inferior 163 (146, 195) 154 (139, 167) 148 (130, 162) 117 (89, 145)* 126 (86, 165) 80 (68, 115)*
Nasal 82 (65, 106) 68 (53, 91) 83 (73, 90) 84 (68, 97) 72 (57, 85) 55 (40, 71)*
Time periods in which the median thickness differs from the thickness at baseline at the P < 0.05 level are marked with an asterisk.
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Inner Nuclear Layer, Outer Plexiform Layer, and
Outer Nuclear Layer
In contrast to the GCL and the IPL, in our patients, the INL,
OPL, and ONL did not thin as the disease progressed, and
there is qualitative evidence that some layers thickened in the
months after diagnosis (Supplementary Figs. S1, S3, S5;
Supplementary Table S1, left). The thickening that was seen
in the layers was not generally correlated with changes in
visual acuity (Supplementary Table 3, right; Supplementary
Figs. S2, S4, S6). In layers where there was an association
between vision and thickness, the association was reversed
from what was found in the RNFL, GCL, and IPL, with worse
eyesight being associated with thickening rather than
thinning.
DISCUSSION
Using the validated and consistent measurement of SD-OCT,
our analysis describes the structural changes occurring in
FIGURE 5. Visual acuity and RNFL thickness.
TABLE 5. Median Thickness of the Ganglion Cell Layer as Symptoms Progress
Median (95%CI)
Presymptomatic
Eye
0.5 mo Before Onset
to 0.5 mo After Onset
0.5–3 mo
After Onset
3–6 mo
After Onset
6–12 mo
After Onset
12–24 mo
After Onset
Center 13 (12, 15) 14 (7, 16) 12 (9, 14) 9 (7, 10)* 9 (8, 11)* 8 (7, 9)*
Nasal inner 53 (46, 55) 42 (26, 56) 31 (24, 37)* 20 (15, 24)* 22 (19, 28)* 20 (18, 26)*
Nasal outer 39 (36, 43) 33 (24, 43) 30 (26, 34)* 24 (21, 27)* 25 (23, 27)* 23 (21, 25)*
Superior inner 55 (49, 58) 48 (35, 56) 36 (29, 44)* 24 (19, 30)* 26 (21, 30)* 21 (18, 27)*
Superior outer 36 (33, 38) 33 (28, 38) 32 (28, 36) 23 (19, 28)* 25 (23, 26)* 22 (20, 24)*
Temporal inner 50 (46, 53) 40 (25, 51) 33 (24, 42)* 19 (17, 24)* 20 (15, 26)* 17 (15, 23)*
Temporal outer 37 (36, 38) 33 (26, 35)* 30 (25, 34)* 22 (20, 24)* 22 (19, 27)* 20 (17, 22)*
Inferior inner 55 (47, 58) 42 (27, 57) 34 (28, 42)* 23 (19, 29)* 28 (22, 35)* 21 (19, 28)*
Inferior outer 33 (32, 35) 30 (25, 33)* 28 (25, 31)* 25 (22, 27)* 26 (24, 29)* 23 (21, 25)*
Time periods in which the median thickness differs from the thickness at baseline at the P < 0.05 level are marked with an asterisk.
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retina in the months around the onset of symptoms in LHON
patients, and suggests thinning of the RNFL, GCL, and IPL,
may drive part of the vision loss experienced by patients with
LHON. We would recommend using GCL as an anatomic
marker of therapeutic effect over RNFL, as our results show a
stronger relationship between these layers and visual acuity.
While our results are not inconsistent with changes in the
RNFL causing vision loss, we were able to identify a
significant difference in the thickness of the GCL and IPL
before changes were conclusively seen in the substructures of
the RNFL. Therefore, when considering evolving treatments
for LHON, early treatment before RNFL shows thinning would
be advised.
Our results establish that the retinal structural changes
evolve during the time around onset of LHON symptoms, and
suggest two distinct response patterns: progressive thinning
that begins around the onset of symptoms, and slows at
approximately 6 months, in which thinning is associated with
vision loss; and swelling around the time of the onset of
symptoms, with increasing thickness associated with vision
loss; the RNFL, GCL, and IPL behave like the former, and the
INL, OPL, and ONL behave like the later.
Compared with previous research, our data are consistent
with reports of a relationship between visual acuity and RNFL
thinning,2 and in contrast to studies that found RNFL
thickening around the time of onset.
FIGURE 6. Ganglion cell layer thickness during LHON progression.
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FIGURE 7. Visual acuity and GCL thickness.
TABLE 6. Median Thickness of the Inner Plexiform Layer as Symptoms Progress
Median (95%CI)
Presymptomatic
Eye
Within 0.5 mo
of Onset
0.5–3 mo
After Onset
3–6 mo
After Onset
6–12 mo
After Onset
12–24 mo
After Onset
Center 19 (17, 21) 20 (16, 22) 19 (16, 21) 15 (14, 16)* 16 (15, 17)* 15 (14, 16)*
Nasal inner 42 (39, 44) 36 (28, 43) 29 (26, 34)* 25 (22, 27)* 25 (23, 27)* 22 (19, 25)*
Nasal outer 30 (28, 33) 28 (20, 32) 25 (22, 27)* 22 (21, 23)* 22 (21, 22)* 22 (21, 23)*
Superior inner 42 (38, 42) 38 (34, 43) 33 (28, 38)* 26 (22, 28)* 25 (23, 27)* 22 (22, 24)*
Superior outer 28 (26, 29) 27 (26, 28) 26 (24, 29) 23 (21, 25)* 23 (22, 25)* 22 (21, 23)*
Temporal inner 41 (39, 42) 39 (25, 44) 34 (28, 39)* 26 (22, 30)* 26 (23, 28)* 22 (18, 26)*
Temporal outer 31 (30, 32) 32 (29, 32) 29 (26, 31) 25 (21, 29)* 25 (22, 26)* 22 (20, 23)*
Inferior inner 43 (39, 43) 37 (29, 42)* 31 (27, 34)* 25 (22, 29)* 26 (24, 29)* 23 (22, 26)*
Inferior outer 27 (26, 27) 26 (24, 26) 23 (22, 25)* 23 (21, 25)* 22 (20, 23)* 20 (20, 22)*
Time periods in which the median thickness differs from the thickness at baseline at the P < 0.05 level are marked with an asterisk.
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Our analysis does have some limitations. Leber’s Hereditary
Optic Neuropathy studies are inherently difficult due to the
inability to identify which carriers will go on to have vision
loss. Although the longitudinal nature of our study provided
multiple observations on each subject, our study enrolled nine
participants. Due to the modest sample size, the complexity of
our statistical models was limited by power considerations.
Although we were able to control for age and within-eye
correlation, we would have additionally liked to control for
other possible confounders, and we would have liked to test to
see if the pattern of swelling and thinning differed by mutation
status. Similarly, due to the sample size, it is possible that the
assumptions of GEE are not fully met, and therefore, although
GEE is still the best way to control for interperson correlation,
the GEE estimates may be unstable. In addition, many patients
present for evaluation only after their initial visual decline, so
the presymptomatic eyes in our cohort are largely from
individuals who have already experienced unilateral vision
loss, which may not represent the true thickness seen in
asymptomatic carriers. Additionally, our analyses tested multi-
ple hypotheses, and therefore the reported statistical signifi-
cance threshold (a ¼ 0.05) does not definitively establish a
causal relationship. However, as the nature of our analysis is
descriptive of the structural changes, we did not design our
study to meet a strict significance threshold such as a
Bonferroni correction.
FIGURE 8. Inner plexiform layer thickness during LHON progression.
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These analyses suggest several paths for future research.
Future studies to examine retinal structure changes in
individuals who regain vision might provide insight in to the
potential protective structural differences that are associated
with this regain of function, which may further suggest
therapeutic targets. It would also be of interest to see if a
threshold of GCL, RNFL, or IPL loss exists in asymptomatic
carriers before visual symptoms occur. Given the dramatic
decline in thickness in the GCL, RNFL, and IPL, changes from
an asymptomatic carriers baseline may indicate that vision loss
is imminent, and present a potential therapeutic window.
In summary, our investigation uses SD-OCT to measure
retinal segmentation and demonstrate a structure-function
relationship between visual acuity and retinal anatomy in
LHON patients. Our findings suggest that the variability in the
RNFL observed by others does not translate to patterns of
retinal ganglion cell death. We suggest that instead of RNFL,
that thinning in the GCL and, to a lesser extent, IPL, may drive
vision loss in LHON patients. In the GCL and IPL, there is
strong evidence of thinning that begins at or immediately
following the onset of symptoms, and the thinning is
associated with vision loss. Our analyses also demonstrate
the greater sensitivity of SD-OCT compared with TD-OCT, and
supports the use of SD-OCT of the GCL as a secondary or
coprimary endpoint in clinical trials, because there is a clear
linear pattern of GCL thinning during the acute phase,
FIGURE 9. Visual acuity and IPL thickness.
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followed by relative preservation of thickness after 6 months. If
these structural changes are verified to be causing the vision
loss, they provide a compelling possibility for therapeutic
targets to slow the progression of vision loss associated with
LHON.
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